Delhi High Court Allows Interim Stay on Ban of Drugs

by Reshma Anand on  March 22, 2016 at 11:45 AM Indian Health News   - G J E 4
On March 10, Union Health Ministry has announced a ban on 355 fixed dose combination drugs in India. Some of the popular drugs include cough syrups like D'Cold, Phensedyl, Benadryl and Corex, Nimesulide and Vicks Action 500 Extra.
Delhi High Court Allows Interim Stay on Ban of Drugs
Delhi High Court Allows Interim Stay on Ban of Drugs

The ban was issued to curb the misuse of medicines in the country. Now, about 30 leading pharmaceutical companies like Pfizer, Glenmark and Cipla have filed petitions against the government's ban. Therefore, the Delhi High Court has announced that it will grant an interim stay on the drug ban till March 28.

‘In an interim relief for pharmaceutical companies, the Delhi High Court has stayed the ban on 355 drugs till March 28.’
This move has offered a breathing relief for drugs manufactured by major pharmaceutical companies like Pfizer's Corex cough syrup, Glaxo's Piriton expectorant, P&G's Vicks Action 500 extra, Reckitt's D'Cold, Piramal's Saridon, Glenmark's Ascoril and Alex cough syrups, Abbott's Phensedyl cough syrup and Alembic's Glycodin cough syrup.

In their pleas, the companies have stated that the ban on drugs under the Drugs and Cosmetics Act and Rules was issued without giving any show-cause notification or granting them a hearing. Therefore, the court has decided to hear their pleas on March 28.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

More News on: